Publication | Closed Access

Co-delivery of Paclitaxel/Atovaquone/Quercetin to regulate energy metabolism to reverse multidrug resistance in ovarian cancer by PLGA-PEG nanoparticles

NanomedicineEnergy MetabolismPlga-peg NanoparticlesPolymer-drug ConjugateMedicineNano-drug DeliveryTumor TargetingAnti-cancer AgentPharmacologyRadiation OncologyTumor BiologyOvarian CancerHealth Sciences